Tatva Chintan Pharma Chem Schedules Q3FY26 Earnings Call for Jan 21, 2026
Tatva Chintan Pharma Chem Limited will hold its Q3FY26 earnings call on January 21, 2026, at 5:00 PM IST, post the announcement of financial results for the quarter and nine months ended December 31, 2025. The call will be hosted by ICICI Securities.
This is a routine announcement regarding the scheduling of a conference call to discuss financial results. It does not contain any new material information about the company's performance or future outlook.
The announcement is a routine scheduling of an earnings call and does not contain any financial results or forward-looking statements that would indicate a positive or negative sentiment.
Tatva Chintan Pharma Chem Limited has announced the schedule for its earnings call following the announcement of financial results for the quarter and nine months ended 31 December 2025. The call is scheduled to take place on Wednesday, 21 January 2026, at 05:00 p.m. Indian Standard Time (IST).
The earnings call will be hosted by ICICI Securities. The company will be represented by Mr. Chintan Shah, Managing Director, and Mr. Ajesh Pillai, Chief Financial Officer. The announcement also includes contact details for the call coordinator and for any clarifications, including email addresses and phone numbers for representatives from ICICI Securities.
What to do with a filing like this
Tatva Chintan Pharma Chem Limited filed this with the NSE as a statutory disclosure, categorised under concall scheduled. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Tatva Chintan Pharma Chem Limited. Read the original for the full detail.